INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2024

Higher soy isoflavone intake was linked to a lower risk of coronary heart disease and overall cardiovascular disease in adults.

Researchers evaluated the link between soy isoflavone intake and cardiovascular outcomes across prospective cohort studies published up to September 2021. High intake was significantly associated with a lower risk of CHD overall (pooled RR: 0.92, 95% CI: 0.85-0.99) and lower risks of CVD (pooled RR: 0.91, 95% CI: 0.84-0.98) and CHD (pooled RR: 0.89, 95% CI: 0.83-0.96) in Western populations. Linear dose-response analysis showed each 3 mg/day increase was associated with a 16% lower risk of CVD and 14% lower risk of CHD in Western populations.

Shows an association, not proof of cause and effect.

Study type
Systematic review and dose-response meta-analysis
Who was studied
Adults from prospective cohort studies (13 publications reviewed, 12 in meta-analysis)
What was measured
Risk of cardiovascular disease (CVD) and coronary heart disease (CHD)

THE PAPER

Soy isoflavone intake and risk of cardiovascular disease in adults: A systematic review and dose-response meta-analysis of prospective cohort studies.

Naghshi S, Tutunchi H, Yousefi M, Naeini F, Mobarak S, Asadi M, Sadeghi O. Crit Rev Food Sci Nutr, 2024.

PubMed 36705465 ↗DOI 10.1080/10408398.2022.2163372 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.